Osseointegration and antibacterial effect of an antimicrobial peptide releasing mesoporous titania implant
Journal article, 2021

Medical devices such as orthopedic and dental implants may get infected by bacteria, which results in treatment using antibiotics. Since antibiotic resistance is increasing in society there is a need of finding alternative strategies for infection control. One potential strategy is the use of antimicrobial peptides, AMPs. In this study, we investigated the antibiofilm effect of the AMP, RRP9W4N, using a local drug-delivery system based on mesoporous titania covered titanium implants. Biofilm formation was studied in vitro using a safranine biofilm assay and LIVE/DEAD staining. Moreover, we investigated what effect the AMP had on osseointegration of commercially available titanium implants in vivo, using a rabbit tibia model. The results showed a sustained release of AMP with equal or even better antibiofilm properties than the traditionally used antibiotic Cloxacillin. In addition, no negative effects on osseointegration in vivo was observed. These combined results demonstrate the potential of using mesoporous titania as an AMP delivery system and the potential use of the AMP RRP9W4N for infection control of osseointegrating implants.

biofilm

Staphylococcus epidermidis

sustained release

rabbit tibia model

Author

Maria Pihl

Chalmers, Chemistry and Chemical Engineering, Applied Chemistry

Silvia Galli

Malmö university

Ryo Jimbo

Malmö university

Martin Andersson

Chalmers, Chemistry and Chemical Engineering, Applied Chemistry

Journal of Biomedical Materials Research - Part B Applied Biomaterials

1552-4973 (ISSN) 15524981 (eISSN)

Vol. 109 11 1787-1795

Subject Categories

Infectious Medicine

Biomaterials Science

Medical Materials

DOI

10.1002/jbm.b.34838

More information

Latest update

4/5/2022 5